Venture Life Group PLC (GB:VLG)
LSE:VLG
UK Market

Venture Life Stock Analysis & Ratings

GB:VLG Stock Chart & Stats

Day’s Range31.8p - 32.56p
52-Week Range20.00p - 118.00p
Previous Close32p
Volume72.67K
Average Volume (3M)562.62K
Market Cap40.42M
P/E Ratio67.6
Beta0.15
Next EarningsSep 22, 2022
EPS ForecastN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score1
EPS (TTM)0.00


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

GB:VLG FAQ

What was Venture Life’s price range in the past 12 months?
Venture Life lowest stock price was 20.00p and its highest was 118.00p in the past 12 months.
    What is Venture Life’s market cap?
    Venture Life’s market cap is 40.42M.
      What is Venture Life’s price target?
      Currently, no data Available
      What do analysts say about Venture Life?
      Not enough analysts have published a price target to provide an average price target.
      When is Venture Life’s upcoming earnings report date?
      Venture Life’s upcoming earnings report date is Sep 22, 2022 which is in 118 days.
        How were Venture Life’s earnings last quarter?
        Currently, no data Available
        Is Venture Life overvalued?
        According to Wall Street analysts Venture Life’s price is currently Overvalued.
          Does Venture Life pay dividends?
          Venture Life pays a Annually dividend of 0p which represents an annual dividend yield of N/A. Venture Life’s last Annually dividend payment was on Jun 22, 2018. Venture Life’s upcoming ex-dividend date is May 24, 2018
            What is Venture Life’s EPS estimate?
            Venture Life’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Venture Life have?
            Venture Life has 126,500,000 shares outstanding.
              What happened to Venture Life’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Venture Life?
              Currently, no hedge funds are holding shares in GB:VLG

              ---

              Venture Life Stock Analysis

              Smart Score
              1
              Underperform
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10
              Price Target
              No data currently available

              Analyst Forecast

              N/A
              Currently Not Enough Data Available

              Blogger Sentiment

              N/A
              Currently Not Enough Data Available

              Hedge Fund Holdings

              N/A
              Currently Not Enough Data Available

              Insider Transactions

              N/A
              Currently Not Enough Data Available

              Retail Investors

              N/A
              Currently Not Enough Data Available

              News Sentiment

              Negative
              Bullish 0% Bearish 100%

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -64.24%
              12-Months-Change

              Fundamentals

              Return on Equity
              N/A
              Trailing 12-Months
              Asset Growth
              N/A
              Trailing 12-Months
              The Venture Life stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Venture Life Group PLC

              Venture Life Group PLC is an international consumer self-care company. The company focuses on developing, manufacturing and commercializing products for the aging population. Its products include Oral Healthcare, Proctology, Dermatology, Neurology, and Women's Healthcare. Its segments include Brands, which includes sales of branded healthcare and cosmetics products direct to retailers and under distribution agreements; and Development and Manufacturing, which includes sales of products and services under contract development and manufacturing agreements. It earns a vast majority of its revenue from the Development and Manufacturing segment in the United Kingdom. Geographically, it also operates in Italy, Switzerland, and other regions.

              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Kromek Group plc
              Kape Technologies Plc
              Mpac Group PLC
              Sylvania Platinum

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis